Century Therapeutics (IPSC) Cash from Financing Activities (2020 - 2026)
Century Therapeutics' Cash from Financing Activities came in at $311,000 for Q2 2026, down 99.8% from the prior quarter.
Powered by 
Analysis
Century Therapeutics (IPSC) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Century Therapeutics reported Cash from Financing Activities of $126.99 million; for FY2025, it came in at $173,000, down 99.8% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of -67.5% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $74.56 million in FY2024, -$9.73 million in FY2023, $27.16 million in FY2022 (-93.5%) and $417.77 million in FY2021 (+776.0%).
- The five-year range for quarterly Cash from Financing Activities is -$10.12 million (Q2 2023) to $126.62 million (Q1 2026).
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q3 2023 (growth of 119.0%), and the weakest in Q2 2022 (a decline of 100.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.37 Bn | 1,134.95 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 643.27 Bn | 563.13 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 358.37 Bn | 312.75 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 301.91 Bn | 265.90 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 267.33 Bn | 241.01 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 241.44 Bn | 196.84 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 193.00 Bn | 167.20 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 171.57 Bn | 118.21 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Century Therapeutics | 329.25 Mn | -175.13 Mn | - | 311,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 311,000.00 |
| Mar 31, 2026 | 126.62 Mn |
| Dec 31, 2025 | 53,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Dec 31, 2024 | -602,000.00 |
| Sep 30, 2024 | 273,000.00 |
| Jun 30, 2024 | 56.70 Mn |
| Mar 31, 2024 | 18.20 Mn |
| Dec 31, 2023 | -356,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | -10.12 Mn |
| Mar 31, 2023 | 448,000.00 |
| Dec 31, 2022 | 95,000.00 |
| Sep 30, 2022 | 137,000.00 |
| Jun 30, 2022 | 48,000.00 |
| Mar 31, 2022 | 26.88 Mn |
| Dec 31, 2021 | 106,000.00 |
| Sep 30, 2021 | -466,000.00 |
| Jun 30, 2021 | 224.65 Mn |
| Mar 31, 2021 | 193.49 Mn |
API Access
Century Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IPSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IPSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IPSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();